A sign of what's coming? Presidential hopeful DeSantis targets PBMs and pharma transparency
As the 2024 presidential election race heats up and cutting drug costs becomes a centerpiece of President Joe Biden’s policy successes to date, Republican hopeful Ron DeSantis has offered up a sign of his own plans for the industry.
DeSantis is calling for all proposed drug price increases to be pre-announced by manufacturers, who would also have to submit an annual report justifying those increases.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.